癌症进展,转移和存活率
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
在PubMed上查看摘要
概括
此摘要是机器生成的。参与血液凝块分解的纤维溶解系统可以促进癌症的进展和转移. 激素激素激活剂 (uPA) 和其受体 (uPAR) 等关键成分驱动瘤的生长和扩散.
科学领域
- 生物化学
- 癌症学
- 分子生物学
背景情况
- 纤维素分析系统主要降解纤维素凝块.
- 在癌症患者中观察到纤维分析系统的异常激活.
- 这种激活会影响癌症的进展,转移和生存.
研究的目的
- 研究纤维溶解系统在癌症进展和转移中的作用.
- 阐明纤维分析成分影响瘤生长和扩散的机制.
主要方法
- 对与癌症结局相关的纤维分析标志物的血水平的临床数据分析.
- 使用小鼠模型评估纤维分析成分对瘤的影响的研究.
主要成果
- 尿素激素激活剂 (uPA) 和其受体 (uPAR) 的升高与各种癌症的癌症进展和转移相关.
- 血α2-抗血复合物的增加与某些癌症的存活率降低有关.
- 鼠标模型表明uPA,UPAR,组织类型等离子体激活剂 (tPA) 和等离子体有助于瘤生长和转移.
结论
- 通过uPA,UPAR,tPA和等离子体,纤维分析系统积极促进癌症的进展.
- 机制包括激活信号通路,通过细胞外基质降解增强瘤细胞迁移,并释放生长因子.
相关概念视频
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...